Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Borison

Showing results (21-30 of 64) with videos related to

Pageof 7
Sort By:
Lancet (London, England)|October 16, 1982
Site of action of thioridazineR L Borison, A J Blowers
Brain Research Bulletin|August 1, 1983
Dyskinesias in the geriatric populationA J Blowers, R L Borison
Psychopharmacology Bulletin|January 1, 1986
Basic and clinical studies of neuroleptic-induced supersensitivity psychosis and dyskinesiaB I Diamond, R L Borison
Life Sciences|October 15, 1975
Brain 2-phenylethylamine as a major mediator for the central actions of amphetamine and methylphenidateR L Borison, A D Mosnaim, H C Sabelli
Life Sciences|July 1, 1977
Chronic phenylethylamine stereotypy in rats: a new animal model for schizophrenia?R L Borison, H S Havdala, B I Diamond
The Journal of the American Board of Family Practice|April 1, 1990
Movement disorders and new azapirone anxiolytic drugsM W Jann, J H Froemming, R L Borison
Anesthesiology|June 1, 1979
Potential hazards and applications of lithium in anesthesiologyH S Havdala, R L Borison, B I Diamond
Psychopharmacology Bulletin|January 1, 1991
Does sigma receptor antagonism predict clinical antipsychotic efficacy?R L Borison, B I Diamond, A T Dren
Psychopharmacology Bulletin|January 1, 1990
Efficacy and safety of a putative anxiolytic agent: ipsapironeR L Borison, J W Albrecht, B I Diamond
Neurology|May 1, 1980
Estrogen in experimental tardive dyskinesiaJ H Gordon, R L Borison, B I Diamond
Pageof 7

Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Lancet (London, England)|October 16, 1982
Site of action of thioridazineR L Borison, A J Blowers
Brain Research Bulletin|August 1, 1983
Dyskinesias in the geriatric populationA J Blowers, R L Borison
Psychopharmacology Bulletin|January 1, 1986
Basic and clinical studies of neuroleptic-induced supersensitivity psychosis and dyskinesiaB I Diamond, R L Borison
Life Sciences|October 15, 1975
Brain 2-phenylethylamine as a major mediator for the central actions of amphetamine and methylphenidateR L Borison, A D Mosnaim, H C Sabelli
Life Sciences|July 1, 1977
Chronic phenylethylamine stereotypy in rats: a new animal model for schizophrenia?R L Borison, H S Havdala, B I Diamond
The Journal of the American Board of Family Practice|April 1, 1990
Movement disorders and new azapirone anxiolytic drugsM W Jann, J H Froemming, R L Borison
Anesthesiology|June 1, 1979
Potential hazards and applications of lithium in anesthesiologyH S Havdala, R L Borison, B I Diamond
Psychopharmacology Bulletin|January 1, 1991
Does sigma receptor antagonism predict clinical antipsychotic efficacy?R L Borison, B I Diamond, A T Dren
Psychopharmacology Bulletin|January 1, 1990
Efficacy and safety of a putative anxiolytic agent: ipsapironeR L Borison, J W Albrecht, B I Diamond
Neurology|May 1, 1980
Estrogen in experimental tardive dyskinesiaJ H Gordon, R L Borison, B I Diamond
Pageof 7